المؤلفون: Neppelenbroek SIM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Geurts YM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Rademakers SE; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., de Weijer RJ; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Schippers MGA; Department of Radiation Oncology, Instituut Verbeeten, Tilburg, the Netherlands., Ta BDP; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Zijlstra JM; Department of Hematology, Amsterdam UMC, Location Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., van der Maazen RWM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Eindhoven, the Netherlands., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Enschede, the Netherlands., Schimmel EC; Department of Radiotherapy, Radiotherapiegroep, Arnhem, the Netherlands., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Böhmer LH; Department of Hematology, Haga Teaching Hospital, Den Haag, the Netherlands., Muller K; Department of Radiotherapy, Radiotherapiegroep, Deventer, the Netherlands., Koene HR; Department of Hematology, St Antonius Hospital, Nieuwegein, the Netherlands., Te Boome LCJ; Department of Hematology, Haaglanden Medical Center, Den Haag, the Netherlands., Bilgin YM; Department of Internal Medicine, Admiraal De Ruyter Hospital, Goes, the Netherlands., de Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Janus CPM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Jun 01; Vol. 42 (16), pp. 1903-1913. Date of Electronic Publication: 2024 Feb 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/epidemiology , Hodgkin Disease*/drug therapy , Doxorubicin*/adverse effects , Doxorubicin*/administration & dosage , Breast Neoplasms*/epidemiology , Breast Neoplasms*/drug therapy , Cancer Survivors*/statistics & numerical data, Humans ; Female ; Adolescent ; Adult ; Middle Aged ; Young Adult ; Antibiotics, Antineoplastic/adverse effects ; Incidence ; Netherlands/epidemiology ; Risk Factors

المؤلفون: Geurts YM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Neppelenbroek SIM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Aleman BMP; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam., Janus CPM; Department of Radiotherapy, Erasmus Medical Centre, Rotterdam., Krol ADG; Department of Radiation Oncology, Leiden University Medical Centre, Leiden., van Spronsen DJ; Department of Hematology, Radboud University Medical Centre, Nijmegen., Plattel WJ; Department of Hematology, University Medical Centre Groningen, Groningen., Roesink JM; Department of Radiotherapy, University Medical Centre Utrecht, Utrecht., Verschueren KMS; Department of Radiation Oncology, Institute Verbeeten, Tilburg., Zijlstra JM; Department of Hematology, Amsterdam UMC location Vrije Universiteit, Cancer Centre Amsterdam, Amsterdam., Koene HR; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein., Nijziel MR; Catharina Cancer Institute, Department of Hemato-Oncology, Catharina Hospital, Eindhoven., Schimmel EC; Radiotherapiegroep, Arnhem., de Jongh E; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht., Ong F; Department of Radiotherapy, Medisch Spectrum Twente, Enschede., Te Boome LCJ; Department of Hematology, Haaglanden Medical Centre, The Hague., van Rijn RS; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden., Böhmer LH; Department of Hematology, Haga Teaching Hospital, The Hague., Ta BDP; Department of Radiation Oncology (MAASTRO), GROW School for Oncology, Maastricht University Medical Centre+, Maastricht., Visser HPJ; Department of Hematology, Noordwest Ziekenhuisgroep Alkmaar, Alkmaar., Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft., Bilgin YM; Department of Internal Medicine, ADRZ, Goes., Muller K; Radiotherapiegroep, Deventer., van Kampen D; Zuidwest Radiotherapeutisch Instituut, Vlissingen., So-Osman C; Department of Hematology, Erasmus Medical Centre, Rotterdam; Unit Transfusion Medicine, Sanquin Blood Supply Foundation, Amsterdam., Vermaat JSP; Department of Hematology, Leiden University Medical Centre, Leiden., de Weijer RJ; Department of Hematology, University Medical Centre Utrecht, Utrecht., Kersten MJ; Department of Hematology, Amsterdam UMC location University of Amsterdam, Cancer Centre Amsterdam and LYMMCARE, Amsterdam, The Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam. Electronic address: m.schaapveld@nki.nl.

المصدر: ESMO open [ESMO Open] 2024 Feb; Vol. 9 (2), pp. 102248. Date of Electronic Publication: 2024 Feb 12.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Second Primary*/epidemiology , Neoplasms, Second Primary*/etiology , Lymphoma, Large B-Cell, Diffuse*/epidemiology, Humans ; Rituximab/adverse effects ; Survivors ; Cyclophosphamide ; Doxorubicin

المؤلفون: Geurts YM; Department of Epidemiology and Biostatistics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Shakir R; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Ntentas G; Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Department of Medical Physics, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK., Roberti S; Department of Epidemiology and Biostatistics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Aznar MC; Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK., John KM; Department of Epidemiology and Biostatistics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Ramroth J; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Janus CPM; Department of Radiotherapy, Erasmus Medical Center, Rotterdam, the Netherlands., Krol ADG; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands., Roesink JM; Department of Radiotherapy, University Medical Center Utrecht, Utrecht, the Netherlands., van der Maazen RWM; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Zijlstra JM; Department of Hematology, Amsterdam University Medical Center, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, the Netherlands., Darby SC; Nuffield Department of Population Health, University of Oxford, Oxford, UK., Aleman BMP; Department of Radiation Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., van Leeuwen FE; Department of Epidemiology and Biostatistics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Cutter DJ; Nuffield Department of Population Health, University of Oxford, Oxford, UK.; Oxford Cancer and Hematology Center, Oxford University Hospitals National Health Service Foundation Trust, Churchill Hospital, Oxford, UK., Schaapveld M; Department of Epidemiology and Biostatistics, the Netherlands Cancer Institute, Amsterdam, the Netherlands.

المصدر: JAMA oncology [JAMA Oncol] 2023 Apr 01; Vol. 9 (4), pp. 481-489.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/drug therapy , Hodgkin Disease*/epidemiology , Hodgkin Disease*/radiotherapy , Colorectal Neoplasms*/epidemiology , Colorectal Neoplasms*/diagnosis, Male ; Humans ; Child ; Female ; Procarbazine/adverse effects ; Case-Control Studies ; Survivors

المؤلفون: Geurts YM; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia., Dugué PA; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia., Joo JE; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia., Makalic E; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia., Jung CH; Melbourne Bioinformatics, University of Melbourne, Parkville, VIC, Australia., Guan W; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Nguyen S; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Grove ML; Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA., Wong EM; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia., Hodge AM; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia., Bassett JK; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia., FitzGerald LM; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia., Tsimiklis H; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia., Baglietto L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Severi G; Human Genetics Foundation (HuGeF), Torino, Italy.; CESP (U1018 INSERM, Équipe Générations et Santé), Facultés de médecine Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France., Schmidt DF; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia., Buchanan DD; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.; Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, VIC, Australia.; University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, VIC, Australia.; Genetic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, VIC, Australia., MacInnis RJ; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia., Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia., Pankow JS; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Demerath EW; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Southey MC; Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Parkville, VIC, Australia., Giles GG; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia., English DR; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia., Milne RL; Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.

المصدر: International journal of obesity (2005) [Int J Obes (Lond)] 2018 Apr; Vol. 42 (4), pp. 887-896. Date of Electronic Publication: 2017 Oct 16.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101256108 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5497 (Electronic) Linking ISSN: 03070565 NLM ISO Abbreviation: Int J Obes (Lond) Subsets: MEDLINE

مواضيع طبية MeSH: Body Mass Index*, DNA/*blood , DNA Methylation/*genetics , Neoplasms/*epidemiology , Neoplasms/*genetics, Adult ; Aged ; Australia/epidemiology ; Cross-Sectional Studies ; Female ; Gene Regulatory Networks/genetics ; Genome-Wide Association Study ; Humans ; Male ; Middle Aged ; Neoplasms/blood

المؤلفون: Geurts YM; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 217, 7500 AE, Enschede, The Netherlands., Witteveen A; Department of Health Technology and Service Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Postbus 217, 7500 AE, Enschede, The Netherlands. a.witteveen@utwente.nl., Bretveld R; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 217, 7500 AE, Enschede, The Netherlands., Poortmans PM; Department of Radiation Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, The Netherlands., Strobbe LJA; Department of Surgical Oncology, Canisius-Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands., Siesling S; Department of Health Technology and Service Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Postbus 217, 7500 AE, Enschede, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organisation, Postbus 217, 7500 AE, Enschede, The Netherlands.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Oct; Vol. 165 (3), pp. 709-720. Date of Electronic Publication: 2017 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*epidemiology , Breast Neoplasms/*pathology, Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/mortality ; Breast Neoplasms/therapy ; Combined Modality Therapy ; Female ; Humans ; Middle Aged ; Neoplasm Grading ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Netherlands/epidemiology ; Patient Outcome Assessment ; Prognosis ; Registries ; Tumor Burden

المؤلفون: Dugué PA; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia. Pierre-Antoine.Dugue@cancervic.org.au.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia. Pierre-Antoine.Dugue@cancervic.org.au., Geurts YM; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia., Milne RL; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia., Lockett GA; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK. j.w.holloway@soton.ac.uk., Zhang H; Division of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, TN, USA., Karmaus W; Division of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, TN, USA., Holloway JW; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

المصدر: Allergy [Allergy] 2016 Oct; Vol. 71 (10), pp. 1501-4.

نوع المنشور: Letter; Comment

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE

مواضيع طبية MeSH: DNA Methylation* , Seasons*, Birth Weight/genetics ; Female ; Fetal Blood ; Humans ; Parturition ; Pregnancy